ReachRxResearch
Home
Research
Sign Up
  1. Home
  2. Research Hub
  3. Workforce exit and work productivity los…

Workforce exit and work productivity loss in adults with and without post-COVID-19 condition: the PRIME post-COVID cohort study

International Journal of Infectious Diseases·June 23Open Access
Infectious DiseasesPractice changingCOVID-19Post-COVID-19 ConditionProspective Cohort StudyAdult

Summary

View source

What was studied

This prospective cohort study (PRIME post-COVID, Netherlands) compared workforce exit, absenteeism, presenteeism, work incapacity, and financial strain over two years among adults with Post-COVID-19 Condition (PCC), those who recovered from COVID-19, and those who never had PCC — all employed as of 2022 and followed through 2024.

Key findings

Two-year workforce exit was 17% in PCC (n=790) vs. 10% in Recovered (n=437) and 9% in Never PCC (n=2,115). Absenteeism and presenteeism were up to 3× higher in PCC and 2× higher in Recovered vs. Never PCC. Work incapacity among non-employed participants was 46% (PCC), 17% (Recovered), and 12% (Never PCC); financial strain reached 54% in non-employed PCC vs. 19% in employed Never PCC.

Study limitations

Self-reported outcomes may introduce bias; participants required a positive COVID-19 test and online access, which may limit generalizability; no pre-infection baseline work productivity data were available.

Clinical implications

Adults with PCC face nearly double the workforce exit rate and up to triple the productivity loss compared to peers without PCC — clinicians should proactively screen for work incapacity and financial strain and connect patients to occupational and rehabilitation support.

Related Questions

Explore related topics

What rehabilitation or occupational interventions improve return to work in patients with long COVID?How does post-COVID condition affect long-term disability and work incapacity rates compared to other post-viral syndromes?What screening tools can clinicians use to identify work productivity loss in patients with post-COVID-19 condition?

Publication Details

Year
2026
Journal
International Journal of Infectious Diseases
Sample Size
n=3,342
Source
View article
Keep scrolling
More content below.
Up Next